Fetal tachycardia: A role for amiodarone as first- or second-line therapy?

Archives of Cardiovascular Diseases

Volumn 101, Issue 10, 2008, Pages 619-627

  Pézarda, Philippe Georses ^a   Boussion, Françoise ^a   Sentilhes, Loïc ^a   Lépinard, Catherine ^a   Couvreur, Marie Hélène ^a   Victor, Jacques ^a   Geslin, Philippe ^a   Descamps, Philippe ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

Amiodarone; Atrial flutter; Fetal tachycardia; Fetus; Supraventricular tachycardia; Ventricular tachycardia

Indexed keywords

AMIODARONE; CIBENZOLINE; DIGOXIN; FLECAINIDE; SOTALOL; VERAPAMIL;

ARTICLE; ATRIOVENTRICULAR CONDUCTION; CLINICAL ARTICLE; CLINICAL PROTOCOL; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG POTENTIATION; DRUG RESPONSE; DRUG SAFETY; FETUS; FETUS DEATH; FETUS HYDROPS; FETUS TACHYCARDIA; GOITER; HEART ATRIUM FLUTTER; HEART FAILURE; HEART VENTRICLE TACHYCARDIA; HORMONE SUBSTITUTION; HUMAN; LOADING DRUG DOSE; MONOTHERAPY; PRIMARY HEALTH CARE; SIDE EFFECT; SUPRAVENTRICULAR TACHYCARDIA; TACHYCARDIA;

EID: 57849093662     PISSN: 18752136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acvd.2008.08.012     Document Type: Article

References (27)

1. Newburger JW, Keane JF. Intrauterine supraventricular tachycardia. J Pediatr 1979;95:780-6.
2. van Engelen AD, Weijtens O, Brenner JI, et al. Management outcome and follow-up of fetal tachycardia. J Am Coll Cardiol 1994;24:1371-5.
3. Simpson JM, Sharland GK. Fetal tachycardias: management and outcome of 127 consecutive cases. Heart 1998;79:576-81.
4. Zimmermann C, de Geeter B, Zimmermann A, Gottwalles Y, Boulenc JM. Fetal supraventricular tachycardia associated with anasarca: poor prognosis despite treatment. Apropos of two cases. Arch Mal Coeur Vaiss 1998;91:655-60.
5. Allan LD, Chita SK, Sharland GK, Maxwell D, Priestley K. Flecainide in the treatment of fetal tachycardias. Br Heart J 1991;65:46-8.
6. Jouannic JM, Delahaye S, Fermont L, et al. Fetal supraventricular tachycardia: a role for amiodarone as second-line therapy? Prenat Diagn 2003;23:152-6.
7. Oudijk MA, Michon MM, Kleinman CS, et al. Sotalol in the treatment of fetal dysrhythmias. Circulation 2000;101:2721-6.
8. Oudijk MA, Ruskamp JM, Ambachtsheer BE, et al. Drug treatment of fetal tachycardias. Paediatr Drugs 2002;4:49-63.
9. Strasburger JF, Cuneo BF, Michon MM, et al. Amiodarone therapy for drug-refractory fetal tachycardia. Circulation 2004;109:375-9.
10. Hansmann M, Gembruch U, Bald R, Manz M, Redel DA. Fetal tachyarrhythmias: transplacental and direct treatment of the fetus - a report of 60 cases. Ultrasound Obstet Gynecol 1991;1:162-8.
11. Bourget P, Pons JC, Delouis C, Fermont L, Frydman R. Flecainide distribution, transplacental passage, and accumulation in the amniotic fluid during the third trimester of pregnancy. Ann Pharmacother 1994;28:1031-4.
12. Oudijk MA, Ruskamp JM, Ververs FF, et al. Treatment of fetal tachycardia with sotalol: transplacental pharmacokinetics and pharmacodynamics. J Am Coll Cardiol 2003;42:765-70.
13. Schmolling J, Renke K, Richter O, Pfeiffer K, Schlebusch H, Holler T. Digoxin, flecainide, and amiodarone transfer across the placenta and the effects of an elevated umbilical venous pressure on the transfer rate. Ther Drug Monit 2000;22:582-8.
14. Kirk CR, Gibbs JL, Thomas R, Radley-Smith R, Qureshi SA. Cardiovascular collapse after verapamil in supraventricular tachycardia. Arch Dis Child 1987;62:1265-6.
15. Vautier-Rit S, Dufour P, Vaksmann G, et al. Fetal arrhythmias: diagnosis, prognosis, treatment; apropos of 33 cases. Gynecol Obstet Fertil 2000;28:729-37.
16. Cuneo BF, Strasburger JF. Management strategy for fetal tachycardia. Obstet Gynecol 2000;96:575-81.
17. Krapp M, Kohl T, Simpson JM, Sharland GK, Katalinic A, Gembruch U. Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia. Heart 2003;89:913-7.
18. Jaeggi E, Fouron JC, Drblik SP. Fetal atrial flutter: diagnosis, clinical features, treatment, and outcome. J Pediatr 1998;132:335-9.
19. Frohn-Mulder IM, Stewart PA, Witsenburg M, Den Hollander NS, Wladimiroff JW, Hess J. The efficacy of flecainide versus digoxin in the management of fetal supraventricular tachycardia. Prenat Diagn 1995;15:1297-302.
20. Strasburger JF. Prenatal diagnosis of fetal arrhythmias. Clin Perinatol 2005;32:891-912, viii.
21. Weiner CP, Landas S, Persoon TJ. Digoxin-like immunoreactive substance in fetuses with and without cardiac pathology. Am J Obstet Gynecol 1987;157:368-71.
22. Khositseth A, Ramin KD, O'Leary PW, Porter CJ. Role of amiodarone in the treatment of fetal supraventricular tachyarrhythmias and hydrops fetalis. Pediatr Cardiol 2003;24:454-6.
23. Schleich JM, Bernard Du Haut Cilly F, Laurent MC, Almange C. Early prenatal management of a fetal ventricular tachycardia treated in utero by amiodarone with long-term follow-up. Prenat Diagn 2000;20:449-52.
24. Marcus FI. Drug interactions with amiodarone. Am Heart J 1983;106:924-30.
25. Widerhorn J, Bhandari AK, Bughi S, Rahimtoola SH, Elkayam U. Fetal and neonatal adverse effects profile of amiodarone treatment during pregnancy. Am Heart J 1991;122:1162-6.
26. Bartalena L, Bogazzi F, Braverman LE, Martino E. Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment. J Endocrinol Invest 2001;24:116-30.
27. Grosso S, Berardi R, Cioni M, Morgese G. Transient neonatal hypothyroidism after gestational exposure to amiodarone: a follow-up of two cases. J Endocrinol Invest 1998;21:699-702.